Targeting aneuploidy in cancer therapy is an area of active research. Some approaches aim to exploit the vulnerabilities of aneuploid cells, such as their dependence on specific cellular pathways for survival. For example, drugs that disrupt the mitotic spindle or inhibit proteins essential for cell cycle progression are being investigated for their potential to selectively kill aneuploid cancer cells.
